Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Han

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid LeukemiaYoon-Chi Han, Jennifer Kahler, Nicole Piché-Nicholas, et al.
Journal of Medicinal Chemistry|January 22, 2020
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase InhibitorsYi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng, et al.
Journal of Medicinal Chemistry|June 24, 2020
Correction to Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase InhibitorsYi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng, et al.
Journal of Geriatric Cardiology : JGC|February 14, 2018
Chinese expert consensus on the non-invasive imaging examination pathways of stable coronary artery diseaseYun-Dai Chen, Wei-Yi Fang, Ji-Yan Chen, et al.
European Journal of Medicinal Chemistry|December 20, 2021
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug designTeng-Kuang Yeh, Jen-Shin Song, Po-Wei Chang, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid LeukemiaYoon-Chi Han, Jennifer Kahler, Nicole Piché-Nicholas, et al.
Journal of Medicinal Chemistry|January 22, 2020
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase InhibitorsYi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng, et al.
Journal of Medicinal Chemistry|June 24, 2020
Correction to Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase InhibitorsYi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng, et al.
Journal of Geriatric Cardiology : JGC|February 14, 2018
Chinese expert consensus on the non-invasive imaging examination pathways of stable coronary artery diseaseYun-Dai Chen, Wei-Yi Fang, Ji-Yan Chen, et al.
European Journal of Medicinal Chemistry|December 20, 2021
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug designTeng-Kuang Yeh, Jen-Shin Song, Po-Wei Chang, et al.
Pageof 19